Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Parathyroid Hormone (PTH) on Osseous Cavity

This study has been completed.
Eli Lilly and Company
Information provided by:
University of Michigan Identifier:
First received: January 12, 2006
Last updated: October 6, 2009
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):